Chronic progressive steroid responsive axonal polyneuropathy: A CIDP variant or a primary axonal disorder?

Muscle and Nerve

Volumn 19, Issue 3, 1996, Pages 365-371

  Uncini, Antonino ^a,d   Sabatelli, Mario ^b   Mignogna, Teresa ^b   Lugaresi, Alessandra ^a   Liguori, Rocco ^c   Montagna, Pasquale ^c  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Clinica Neurologica   (Italy)

Author keywords

antiganglioside antibodies; chronic axonal polyneuropathy; chronic idiopathic neuropathy; chronic inflammatory demyelinating polyradiculoneuropathy; steroid treatment

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GM2; PREDNISONE; STEROID;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DEMYELINATING NEUROPATHY; DOSE RESPONSE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; MALE; MOTOR NERVE CONDUCTION; MOTOR NEUROPATHY; POLYRADICULITIS; PRIORITY JOURNAL; PROTEIN CONTENT; SURAL NERVE;

ADOLESCENT; ADULT; AGED; AXONS; BIOPSY; CHRONIC DISEASE; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEURAL CONDUCTION; POLYRADICULONEUROPATHY; PREDNISONE; STEROIDS; SURAL NERVE;

EID: 0030042906     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199603)19:3<365::AID-MUS14>3.0.CO;2-R     Document Type: Article

References (33)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force: Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.
2. Asbury AK, Cornblath DR: Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27:521.
3. Austin JH: Recurrent poly neuropathies and their corticosteroid treatment: with five year observations of a placebocontrolled case treated with corticotrophin, cortisone and prednisone. Brain 1985;81:157-192.
4. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR: Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course and recommendation for diagnostic criteria. Arch Neurol 1989;46:878-884.
5. Chroni E, Hall SM, Hughes RAC: Chronic relapsing axonal neuropathy: a first case report. Ann Neurol 1995;37: 112-115.
6. Corvisier N, Vallat JM, Hugon J, Lubeau M, Dumas M: Les polyneuropathies de cause indeterminée. Rev Neurol 1987; 143:279-283.
7. Cros D, Triggs W: There are no neurophysiologic features characteristic of "axonal" Guillain-Barré syndrome. Muscle Nerve 1994; 17:675-677.
8. DeVivo DC, Engel WK: Remarkable recovery of a steroid-responsive recurrent polyneuropathy. J Neurol Neurosurg Psychiatry 1970;33:62-69.
9. Dyck PJ, Lais AC, Ohtha M, Bastrom JA, Okazaki H, Groover RV: Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50:621-637.
10. Dyck PJ, O'Brien PC, Oviatt KF, Dinapoli RP, Daube JR, Bartleson JD, Mokri B. Swift T, Low PA, Windebank AJ: Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982;11:136-141.
11. Dyck PJ, Prineas J, Pollard J: Chronic inflammatory demy-elinating polyradiculoneuropathy, in Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds): Peripheral Neuropathy (3rd ed). Philadelphia. Saunders, 1993, pp. 1498-1516.
12. Dyck PJ: Is there an axonal variety of GBS? Neurology 1993; 43:1277-1280.
13. Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WJ, Zochodne DW: An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109: 1115-1126.
14. Feasby TE: Axonal Guillain-Barré syndrome. Muscle Nerve 1994:678-679.
15. Fjuii H, Kondo T. Yasuda K, Hiraizumi Y, Yamazaki M, Yuki N: An acute axonal form of Guillain-Barré syndrome with autoantibody against ganglioside GD1b: a case report. No To Hattatsu 1993;25:379-384.
16. Gregson XA, Jones D, Thomas PK, Willison HJ: Acute motor neuropathy with antibodies to GM1 ganglioside. J Neurol Sci 1991;238:447-451.
17. Hughes RAC, Rees JH: Guillain-Barré syndrome. Curr Opin Neurol 1994;7:386-392.
18. Julien J, Vital C, Lagueny A, Ferrer X, Brechenmacher C: Chronic relapsing idiopathic polyneuropathy with primary axonal lesions. J Neurol Neurosurg Psychiatry 1989;52: 871-875.
19. Magi S, Sabatelli M, Mignogna T, Porcu C, Tonali P: Acute axonal idiopathic polyneuropathy: a Guillain-Barré syndrome variant? Ital J Neurol Sci 1992;13:481-486.
20. Matthews WB, Howell DA, Hughes RAC: Relapsing corticosteroid-dependent polyneuritis. J Neurol Neurosurg Psychiatry 1970;33:330-337.
21. McLeod JG, Tuck RR, Pollard JD, Cameron J, Walsh JC: Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry 1984;47:530-535.
22. Mendell JR, Kolkin S, Kissel JT, Weiss KL, Chakerers DW, Rammohan KV: Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1987;37:1291-1294.
23. Nobile Orazio E, Carpo M, Meucci N, Grassi MP, Capitani E, Sciacco M, Mangoni A, Scarlato G: Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies. J Neurol Sci 1992;109:200-206.
24. Notermans N, Wokke JHJ, Franssen H, van der Graaf Y, Vermeurlen M, van den Berg LH, Bar PR, Jennekens FGI: Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993;56:1066-1071.
25. Oh SJ: Subacute demyelinating polyneuropathy responding to corticosteroid treatment. Arch Neurol 1978;35: 509-516.
26. Pollard JD, McLeod JG, Gatemby PA, Kronenberg H: Prediction of response to plasma exchange in chronic relapsing polyneuropathy. A clinico-pathological correlation. J Neurol Sci 1983;58:269-287.
27. Sadiq SA, Thomas FP, Kilidireas K, Protopsaltis S, Hays AP, Lee K-W, Romas SN, Kumar N, van den Berg L, Santoro M, Lange DJ, Younger DS, Lovelace RE, Trojaborg W, Sherman WH, Miller JR, Minuk J, Fehr MA, Roelofs RI, Hollander D, Nichols FT, Mitsumoto H, Kelley JJ, Swift TR, Munsat TL, Latov N: The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 1990; 40:1067-1072.
28. Thomas PK, Walker RWH, Rudge P, Morgan-Hughes JA, King RMN, Jacobs JM, Mills KR, Ormerod IEC, Murray NMF, McDonald WWI: Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain 1987;110:53-76.
29. Uncini A, Di Muzio A, Sabatelli M, Magi S, Tonali P, Gambi D: Sensitivity and specificity of diagnostic criteria for conduction block in chronic inflammatory demyelinating polyneuropathy. Electroencephalogr Clin Neurophysiol 1993;89: 161-169.
30. Walsh FS, Cronin M, Koblar S, Doherty P, Winer J, Leon A, Hughes RAC: Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillan-Barre syndrome. J Neuroimmunol 1991;34:43-51.
31. Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K, Handa S, Miyatake T: A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-1775.
32. Yuki N, Yoshino H, Sato S, Shinozawa K, Miyatake T: Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 1992; 15:899-903.
33. Yuki N: Pathogenesis of axonal Guillain-Barré syndrome: hypothesis. Muscle Nerve 1994;17:680-682.